Misoprostol 3, 4, or 5 days after methotrexate for early abortion: A randomized trial

Contraception

Volumn 56, Issue 3, 1997, Pages 169-174

  Carbonell I Esteve, Josep Lluis ^a,c   Velazco, A ^b   Varela, L ^b   Cabezas, E ^b   Fernandez C ^b   Sanchez C ^b  

^a Foundation for the Promotion of Health and Biomedical Research of Valencia Region   (Spain)

^b Hosp Docente Gineco Obstetrico E   (Cuba)

^c Mediterranea Medica Clinic   (Spain)

Author keywords

Methotrexate; Misoprostol; Pregnancy termination

Indexed keywords

METHOTREXATE; MISOPROSTOL;

ABORTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MIGRAINE; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; RASH;

ABORTIFACIENT AGENTS--ADMINISTRACTION AND DOSAGE; ABORTION FAILURE; ABORTION, DRUG INDUCED; ABORTION, INDUCED; AMERICAS; BIOLOGY; CARIBBEAN; CLINICAL RESEARCH; CLINICAL TRIALS; CUBA; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; ENDOCRINE SYSTEM; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; LATIN AMERICA; MISOPROSTOL--ADMINISTRACTION AND DOSAGE; NORTH AMERICA; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; RESEARCH METHODOLOGY; RESEARCH REPORT; TIME FACTORS;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; FEMALE; HUMANS; METHOTREXATE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 0342617587     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00121-2     Document Type: Article

References (12)

1. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
2. Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 1993;168: 1759-65.
3. Fernandez H, Benifla JL, Lelaidier C, et al. Methotrexate treatment of ectopic pregnancy: 100 cases treated by primary transvaginal injection under sonographic control. Fertil Steril 1993;59:773-7.
4. Schiff E, Shalev E, Bustan M, et al. Pharmacokinetics of methotrexate after tubal local injection for conservative treatment of ectopic pregnancy. Fertil Steril 1992;57: 688-90.
5. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol 3 and 7 days following methotrexate for early abortion. Am J Obstet Gynecol 1995;173:1578-84.
6. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 1996;53:321-7.
7. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333:537-40.
8. Carbonell JL, Varela L, Velazco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997;55:165-8.
9. Schaff E, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995;4:774-9.
10. Goldstein S. Embryonic ultrasonographic measurements: crown-rump length revisited. Am J Obstet Gynecol 1991;165:497-50.
11. Alfonso L. La Quimioterapia de las Enfermedades Malignas. Havana, Cuba: Editorial Científico-Tecnica, 1986:270.
12. Donner A. Approaches to sample size estimations in the design of clinical trials. Stat Med 1984;3:199-214.